How do I follow a methadone program withdrawal guide safely?

If you are enrolled in a methadone program and thinking about tapering or stopping, this methadone program withdrawal guide gives a safety-first sequence to use with your clinic. It is written for patients and families in Ontario and for clinicians who want a clear, patient-facing plan. Do not use this article as a substitute for direct clinical advice. Always agree a supervised plan with your treating team.

Step-by-step plan to follow with your clinic

Use these ordered steps as a checklist to discuss with your nurse and physician. Each numbered step is an explicit decision point where clinicians may pause, slow, or change the plan.

1. Tell your clinic first. Start the conversation with your nurse or prescriber. Road To Recovery clinics offer same-day triage by a nurse and physician for new OAT intakes, and they can begin a supervised plan quickly; you can read about clinic services in the program overview on the Road To Recovery site.
2. Clinical review and baseline measures. Your team will document current dose history, recent substance use, physical and mental health status, pregnancy risk, housing and supports, and medications that could interact with tapering. Clinical guidance describes withdrawal as uncomfortable but usually not life-threatening when supervised, and this review guides safety decisions (withdrawal management guidance).
3. Agree a supervised taper schedule. The clinic will propose an individualized taper and mark explicit stop points where reductions pause if withdrawal emerges. The widely used example schedule is provided below and is a starting template rather than a fixed prescription.
4. Prescribe a symptom-management plan. This often includes short-term medicines for nausea, diarrhoea, insomnia, and anxiety, plus hydration instructions and when to call for help.
5. Set a follow-up and contingency plan. Book early follow-up (phone or in-person) in the first two weeks and agree how to re-stabilize or convert to a different OAT if symptoms become intolerable.
6. Arrange psychiatry or psychosocial supports if needed. Road To Recovery coordinates psychiatry referrals locally or virtually when mental health care is needed during a taper.
7. Document informed consent and safety checks. The clinic should record the agreed taper, anticipated side effects, emergency contacts, and the plan for pauses or reversals.

Deciding whether to start a taper now

Deciding when to begin a taper is a shared decision. Discuss these practical criteria with your clinician:

• Clinical stability on a steady methadone dose without recent problematic illicit opioid use.
• Reliable housing, access to food and hydration, and adult supports who can help if symptoms emerge.
• No untreated severe mental health conditions or uncontrolled medications that raise risk.
• Pregnancy plans, breastfeeding, or childcare needs, since these change clinical priorities and mandatory reporting obligations should be discussed with staff.
• Awareness of formulation changes: some patients experience earlier than expected withdrawal after formulation switches and need close monitoring.

Clinical guidelines note that withdrawal can be extremely uncomfortable but is rarely life-threatening with appropriate care, and that repeated unassisted attempts often lead to relapse and benefit from maintenance treatment or alternative OAT rather than unsupervised stopping (withdrawal management guidance).

An example taper schedule clinicians use

Below is an example schedule drawn from clinical guidance. This is an illustrative framework clinicians commonly adapt to each patient. Do not self-adjust your dose without supervision.

• Reduce methadone by about 10 mg per week until the dose reaches approximately 40 mg per day.
• From 40 mg per day, reduce by about 5 mg per week until discontinuation.
• If withdrawal symptoms appear, slow the taper, pause reductions, or return to the last tolerated dose until symptoms settle; in some cases maintain a reduced dose for several weeks before continuing the taper.

This example is taken from established methadone maintenance guidance and should be adapted to patient tolerance, duration of prior methadone therapy, and co-occurring conditions (methadone maintenance treatment guidance).

Common withdrawal symptoms and typical timeline

Opioid withdrawal commonly feels like a severe flu and can include:

• Early symptoms: yawning, sweating, runny nose, anxiety, restlessness.
• Progressive symptoms: muscle aches, nausea, vomiting, diarrhoea, abdominal cramps, sleep disturbance.
• Psychological symptoms: low mood, irritability, cravings, or anxiety.

Onset and intensity depend on methadone dose, how long you have taken methadone, and other health factors. Symptoms may begin sooner if a product formulation changes, so report any unexpected timing to your clinic immediately. Symptom management and close follow-up reduce risk and support completion of an agreed taper (withdrawal management guidance).

Safety limits and warning signs: when to pause taper and when to seek urgent care

Pause the taper and contact your clinic if you experience: severe dehydration from vomiting or diarrhoea, inability to keep fluids down, suicidal thoughts or new psychosis, seizure activity, chest pain, or breathing difficulty. If you have uncontrolled vomiting, fainting, or severe confusion, go to emergency care or call emergency services.

Be especially alert after any change in methadone product. Canadian reports describe patients who experienced earlier-than-expected withdrawal when formulations changed, which can destabilize care if not managed promptly. If this happens, clinics may reissue the former product when possible or adjust dosing and monitoring (formulation alert).

Switching or transferring to other medication-assisted treatments

If a taper to zero is not the right option, clinicians commonly consider:

• Conversion to buprenorphine/naloxone (Suboxone). This requires careful timing because starting buprenorphine too early can precipitate withdrawal; induction protocols vary and need clinical supervision and sometimes a period of lower methadone dose before switch.
• Monthly buprenorphine injection (Sublocade) for people stabilized on buprenorphine; this option requires prior induction onto daily buprenorphine and a different process than methadone tapering.
• Morphine-based alternatives (Kadian) under specialist guidance in selected cases.

Discuss risks and timing with your prescriber; switching rather than tapering to zero is often safer for people at higher relapse risk. For national program rules and information about methadone in Canada, see Health Canada’s Methadone Program page (Health Canada Methadone Program).

Bring this to your taper appointment

Print or save this checklist and bring it to your clinic visit so you and your team can agree the plan quickly.

• Current methadone dose history for the last month (daily doses and any missed doses).
• All prescription, over-the-counter, and herbal medications.
• Recent substance use and any patterns of non-prescribed opioid use.
• Contact details for a support person who can help during difficult days.
• Questions to ask: How fast will we reduce? What medicines will you give for symptoms? When do I call or come in? What is the contingency plan?
• Childcare, work, and transport arrangements for the first two weeks after dose changes.

Ontario resources, clinic logistics and what Road To Recovery offers

Road To Recovery operates outpatient addiction treatment clinics across Ontario and provides multiple medication options for opioid use disorder, including methadone, Suboxone, Sublocade, and Kadian. New OAT intakes are triaged by a nurse and then seen by a physician on the same day, and intake is streamlined via a secure online portal to help people begin care quickly. For clinic-specific program details, see the methadone maintenance program guide on the Road To Recovery site.

For authoritative national guidance and program information, consult Health Canada’s Methadone Program page. For regional clinical practice and withdrawal management guidance, read standard clinical resources such as the NCBI withdrawal management and methadone maintenance treatment guidance cited above.

For clinicians: shared decision making checklist and documentation points

When supervising a taper, document the following: informed consent discussion, agreed dose reductions with dates, symptom-management prescriptions and thresholds for pausing, mental health risk assessment, contingency arrangements to re-stabilize or transfer to alternative OAT, and contact methods for urgent problems. Use published guidelines when deciding reduction pace and when to slow or pause the taper (methadone maintenance guidance).

Frequently asked questions

Key sources used in this guide include withdrawal management and methadone maintenance guidance to ensure taper examples and safety limits reflect established clinical practice. For further reading, see the national and clinical guidance pages linked above.

Road To Recovery

Ready to plan a supervised taper or discuss alternatives? Contact Road To Recovery through the website to start your intake or to book a nurse assessment today.